Β-Arrestin: A Signaling Molecule and Potential Therapeutic Target for Heart Failure

Journal of Molecular and Cellular Cardiology - United States
doi 10.1016/j.yjmcc.2010.11.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Endothelium as a Therapeutic Target in Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

The Elabela-Apj Axis: A Promising Therapeutic Target for Heart Failure

Heart Failure Reviews
Cardiovascular MedicineCardiology
2020English

STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Understanding Worsening Heart Failure as a Therapeutic Target: Another Step Forward?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Β-Arrestin–biased Signaling Mediates Memory Reconsolidation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Activation of Endothelial Β-Catenin Signaling Induces Heart Failure

Scientific Reports
Multidisciplinary
2016English

Β Blockers for Heart Failure

British Medical Journal
Medicine
2016English

The Lymphotoxin Β Receptor Is a Potential Therapeutic Target in Renal Inflammation

Kidney International
Nephrology
2016English

Author Correction: Notch Signaling Pathway Is a Potential Therapeutic Target for Extracranial Vascular Malformations

Scientific Reports
Multidisciplinary
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy